Effects and Causes of Detraining in Athletes Due to COVID-19: A Review
Open Access
- 28 April 2022
- journal article
- review article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (9) , 5400
Abstract
Several aspects of systemic alterations caused by the SARS-CoV-2 virus and the resultant COVID-19 disease have been currently explored in the general population. However, very little is known about these particular aspects in sportsmen and sportswomen. We believe that the most important element to take into account is the neuromuscular aspect, due to the implications that this system entails in motion execution and coordination. In this context, deficient neuromuscular control when performing dynamic actions can be an important risk factor for injury. Therefore, data in this review refer mainly to problems derived in the short term from athletes who have suffered this pathology, taking into account that COVID-19 is a very new disease and the presented data are still not conclusive. The review addresses two key aspects: performance alteration and the return to regular professional physical activity. COVID-19 causes metabolic-respiratory, muscular, cardiac, and neurological alterations that are accompanied by a situation of stress. All of these have a clear influence on performance but at the same time in the strategy of returning to optimal conditions to train and compete again after infection. From the clinical evidence, the resumption of physical training and sports activity should be carried out progressively, both in terms of time and intensity.Keywords
Funding Information
- Caja Rural Soria and ISABIAL (190290)
This publication has 113 references indexed in Scilit:
- Effects of Physical Activity and Inactivity on Muscle FatigueFrontiers in Physiology, 2012
- Seasonal Variation in Physiological Fitness of a Semiprofessional Soccer TeamJournal of Strength & Conditioning Research, 2009
- Severe Acute Respiratory Syndrome Coronavirus Infection Causes Neuronal Death in the Absence of Encephalitis in Mice Transgenic for Human ACE2Journal of Virology, 2008
- RNA interference shows interactions between mouse brainstem angiotensin AT1 receptors and angiotensin‐converting enzyme 2Experimental Physiology, 2008
- Trauma and Stress Response Among Hurricane Katrina EvacueesAmerican Journal of Public Health, 2007
- Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin systemAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2007
- Effects of AM3 (Inmunoferon®) on increased serum concentrations of interleukin-6 and tumour necrosis factor receptors I and II in cyclistsJournal of Sports Sciences, 2006
- Rhabdomyolysis associated with acute renal failure in patients with severe acute respiratory syndromeInternational Journal Of Clinical Practice, 2005
- Multiple organ infection and the pathogenesis of SARSJournal of Experimental Medicine, 2005
- Protection against muscle damage in competitive sports players: the effect of the immunomodulator AM3Journal of Sports Sciences, 2004